IL17A and Alzheimer disease: Prior research found that AD patients had no change in the total number of CD4+ and CD8+ cells but an increased percentage of circulating immune cells, particularly lymphocytes that generate IL-17, IL-6, IL-22, and IFN-γ (Gouya et al., 2014).